Mineralys Therapeutics Inc.

MLYS | NASDAQ

Price Alert Chart Builder DCF Calculator

$28.31

+$0.29 (+1.03%)

At close: Sep 21, 2026, 4:00 PM ET

$28.35

+$0.04 (+0.14%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $2.47B

Enterprise Value $1.93B

Beta 0.68

Average Volume 1.27M

Shares Outstanding (Diluted) 84.73M

Shares Change YoY 29.45%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US6031701013

Price Performance

Price Change 1M 8.7%

Price Change 3M 10.5%

Price Change 6M 15.0%

Price Change YTD -20.7%

Price Change 1Y -27.0%

Price Change 3Y 163.6%

Price Change 5Y 53.5%

1M CAGR (ann.) 3.8%

1Y CAGR (ann.) -24.9%

5Y CAGR (ann.) N/A

All-Time CAGR 12.3%

Valuation

PE Ratio -6.68

Forward PE N/A

PEG Ratio 0.06

Forward PEG 0.14

PS Ratio N/A

Forward PS 28.10

PB Ratio 4.53

P/FCF Ratio -17.98

P/Adj. FCF Ratio -15.23

P/OCF Ratio -17.26

EV/Sales N/A

EV/EBIT -5.53

EV/EBITDA -5.53

EV/FCF -13.92

Earnings Yield -15.0%

FCF Yield -5.6%

Adj. FCF Yield -6.6%

Financial Health

Net Cash $563.8M

Total Debt $97.62M

Cash & Short-Term Investments $661.41M

Total Assets $667.85M

Current Ratio 34.46

Quick Ratio 34.46

Debt / Equity Ratio 0.18

Debt / EBITDA -0.28

Debt / FCF -0.70

OCF / Debt -1.42

Interest Coverage 0.00

Altman Z-Score 10.56

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -18.0%

Returns

Return on Assets -52.3%

Return on Equity -58.0%

Return on Invested Capital -57.2%

Return on Capital Employed -57.2%

Return on Tangible Assets -52.3%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -21.8%

EPS CAGR 5Y 15.1%

EPS CAGR 10Y N/A

FCF CAGR 3Y -14.5%

FCF CAGR 5Y -45.3%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y 48.3%

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $43.20

Price Target Upside 52.6%

Cash Flow

Operating Cash Flow $-138.79M

Free Cash Flow $-138.8M

Adj. Free Cash Flow $-163.83M

FCF Per Share -$1.64

OCF Per Share -$1.64

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-21K

Operating Income $-370.79M

EBITDA $-349.54M

Net Income $-349.58M

EPS (Diluted) -$4.24

Revenue / Employee N/A

Profit / Employee $-4.6M

Employees 76